AMBS FRIDAY GAZELLE PLAY Amarantus BioScience to Hold

New Post Public Reply Private Reply Replies (0) Message Board

Apr 5, 2013 at 8:47 AM

AMBS >>FRIDAY GAZELLE PLAY

Amarantus BioScience to Hold Business Update Conference Call on April 16

2013-04-05 08:00 ET - News Release

SUNNYVALE, Calif. -- (Business Wire)

Amarantus BioScience, Inc. (OTCQB: AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases associated with neurodegeneration and apoptosis, today announced it will hold a conference call on Tuesday, April 16, 2013 at 4:30 p.m. Eastern (1:30 p.m. Pacific) to provide an update on its business and conduct a question and answer session with investors.

Individuals interested in listening to the conference call may do so by dialing 877-407-8033, or for international callers 201-689-8033. The call is also being webcast, and can be accessed from the Company’s Web site (www.amarantus.com) and at www.InvestorCalendar.com.

A telephone replay will be available through May 1, 2013 by dialing 877-660-6853, or for international callers 201-612-7415, and entering the Conference ID #: 411612. The webcast replay will be available for 90 days following the completion of the call.

During the call Amarantus Chief Executive Officer Gerald Commissiong will recap key accomplishments of 2012 and the first quarter of 2013, provide clarity on the Company’s recently updated business model and discuss business and product development initiatives planned for the remainder of 2013.

About Amarantus BioScience

Amarantus BioScience, Inc. is a development-stage biotechnology company founded in January 2008. The Company is focused on developing unique products and proprietary technologies for the potential treatment and/or diagnosis of Parkinson's disease, Traumatic Brain Injury, Ischemic Heart Disease and other human diseases. The Company owns the intellectual property rights to Mesencephalic-Astrocyte-derived Neurotrophic Factor ("MANF") and is developing MANF-based products as treatments for neurological disorders where there is a significant unmet medical need. The Company also is a Founding Member of the Coalition for Concussion Treatment (#C4CT), a movement initiated in collaboration with Brewer Sports International seeking to raise awareness of new treatments in development for concussions and related nervous-system disorders. For further information please visit www.Amarantus.com.

Forward Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about the possible progress of the MANF technology in testing for Parkinson’s disease, as well as statements about expectations, plans and prospects of the development of Amarantus' diagnostic product candidates. These forward-looking statements are subject to a number of risks, uncertainties and assumptions, including the risks associated with development of therapeutic drug candidates, as well as the risks, uncertainties and assumptions relating to the development of Amarantus' new product candidates, including those identified under "Risk Factors" in Amarantus' most recently filed Annual Report on Form 10-K and Quarterly Report on Form 10-Q and in other filings Amarantus periodically makes with the SEC. Actual results may differ materially from those contemplated by these forward-looking statements. Amarantus does not undertake to update any of these forward-looking statements to reflect a change in its views or events or circumstances that occur after the date of this presentation.

Contacts:

Investor/Media Contact
LHA
Don Markley, Senior Vice President
310-691-7100
dmarkley@lhai.com

Source: Amarantus BioScience, Inc.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bongiorno Probes Deadly Brooklyn Building Collapse

A Grim Scene Unfolds in Flatbush, Brooklyn Some days start with headlines you'd rather not see, and November 11, 2026, painted a picture straight out of a nightmare. A building went belly-up in the heart of Brooklyn's Flatbush neighborhood, leaving a tragic tally in its wake—8 dead, including two kids, and 18 others carrying the burden of injuries. We're staring down...

Alliant's Ritchie Earns Titan 100 Honor—A Leader's Impact

Ritchie's Recognition: An Ongoing Leadership Journey When leadership is genuine, it resonates through the ranks all the way to the community. That's exactly what Meredith Ritchie, EVP at Alliant Credit Union, has been doing—and it shows as she nabs the Chicago Titan 100 accolade yet again in 2027. These folks at Titan 100 don’t hand out participation trophies;...

Gates Unveils ThermalCool 2100SS: A Game-Changer?

Breaking into Unseen Data Center Challenges When you cram more computing power into a single rack than ever before, every single part better pull its weight. Gates Industrial Corporation Ltd. (NYSE: GTES) just threw down the gauntlet with their new toy: the ThermalCool™ 2100SS Pump. Number crunching ain't just about the processor or memory anymore. If the cooling system...

New Dog Leash Innovation Eases Dog Owner Struggles

A real game-changer in dog-walking gear could be sitting right under our noses, and it's coming straight from an inventor in Grand Junction, Colorado. Picture this: you're navigating a tight store aisle, juggling a toddler, a shopping cart, and a squirming dog. This ain't exactly the time for your leash to make life harder. Enter the SHOP & WALK DOG LEASH. This doohickey...

Zoomlion Unveils AI-Powered Gear at bauma CHINA 2026

Setting the Stage for AI in Construction Now here's a scene that's hard to ignore—Zoomlion strutting its stuff at bauma CHINA 2026, putting over 60 examples of its AI-powered, new-energy technologies front and center. It's not every day we see a massive leap this big in the industry, and this November in Shanghai, Zoomlion's got plans to make sure we don't quickly...

HitPaw Shakes Up Black Friday with AI Tool Discounts

HitPaw's AI-Powered Black Friday Splash You wake up on a blustery November day, and bam, HitPaw throws down the gauntlet with one mighty tempting Black Friday offer. We're talking about savings running up to a jaw-dropping 60% on some pretty nifty AI-powered creative tools. Now, whether you’re a seasoned content creator or just someone looking to shake up your Instagram...

Navigating IRS Notices: CPA Morones' Key Steps

When the IRS Knocks: Don't Panic, Get Organized Picture this, you head home after a grinding day only to find a letter from the IRS lurking in your mailbox. For taxpayers in Southwest New Mexico, as CPA Mike Morones out of Silver City puts it, the blood pressure spikes are real. But as Morones assures, most of these letters don't signal doomsday scenarios. Instead,...

Lilly's $3.5B Bet: Next-Gen Obesity Drug Site

Pennsylvania Becoming a Pharma Hub There's a big pharma shuffle happening in the heart of Pennsylvania, folks. Eli Lilly's throwing a whopping $3.5 billion into a new facility in Lehigh Valley, marking it the latest pawn in their larger $50 billion strategy to bolster medicine production right here in the U.S. You talk about commitment, and this investment is no small...

ACR Poker's $20M OSS: Stakes High on Sunday Action

ACR Poker Takes the Spotlight with a Mammoth Sunday Sunday, November 15 is about to be a slugfest over at ACR Poker, as players gear up for an intense day of card-shuffling and betting. We’re looking at flights for all four headlining events of the Online Super Series (OSS) right alongside day two of The Quattro and an eye-popping WSOP Paradise Mega Satellite blowing...

Smart Banner Choices: Decisions Beyond Design

Location, Location, Location: Banner Insights Picking a banner isn't just a quick snap decision. You got to think big, and location is a starting line. Adam Norsworthy from Minuteman Press underscores that understanding how and where this piece of publicity will hang matters more than you might guess. Outdoor or indoor isn't just a weather question; it's a matter of...